Zivo Bioscience, Inc. ZIVO
We take great care to ensure that the data presented and summarized in this overview for Zivo Bioscience, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ZIVO
Top Purchases
Top Sells
About ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
Insider Transactions at ZIVO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2024
|
Laith L Yaldoo Director |
BUY
Open market or private purchase
|
Indirect |
3,133
+0.58%
|
$46,995
$15.96 P/Share
|
|
Oct 16
2024
|
John Bernard Payne President and CEO |
BUY
Open market or private purchase
|
Direct |
6,343
+44.51%
|
$95,145
$15.76 P/Share
|
|
Aug 22
2024
|
Alison A Cornell |
BUY
Open market or private purchase
|
Direct |
11,990
+4.44%
|
$95,920
$8.34 P/Share
|
|
Aug 22
2024
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
31,336
+5.91%
|
$250,688
$8.34 P/Share
|
|
Jul 26
2024
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
2,080
+0.44%
|
$16,640
$8.05 P/Share
|
|
Jun 12
2024
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
3,764
+0.8%
|
$26,348
$7.97 P/Share
|
|
Jun 11
2024
|
Nola E Masterson |
BUY
Grant, award, or other acquisition
|
Direct |
6,273
+4.89%
|
-
|
|
Jun 11
2024
|
Christopher D. Maggiore |
BUY
Grant, award, or other acquisition
|
Direct |
6,273
+1.34%
|
-
|
|
Jun 11
2024
|
Alison A Cornell |
BUY
Grant, award, or other acquisition
|
Direct |
6,273
+2.49%
|
-
|
|
Jun 05
2024
|
Christopher D. Maggiore |
BUY
Grant, award, or other acquisition
|
Direct |
118,174
+12.07%
|
$827,218
$7.96 P/Share
|
|
Jun 05
2024
|
Alison A Cornell |
BUY
Grant, award, or other acquisition
|
Direct |
155,858
+28.99%
|
$1,091,006
$7.96 P/Share
|
|
Jun 05
2024
|
Nola E Masterson |
BUY
Grant, award, or other acquisition
|
Direct |
114,951
+45.8%
|
$804,657
$7.96 P/Share
|
|
May 31
2024
|
Alison A Cornell |
BUY
Grant, award, or other acquisition
|
Direct |
37,688
+31.01%
|
-
|
|
Jan 02
2024
|
Alison A Cornell |
BUY
Open market or private purchase
|
Direct |
41,666
+37.76%
|
$41,666
$1.2 P/Share
|
|
Dec 29
2023
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
157,692
+31.89%
|
$157,692
$1.3 P/Share
|
|
Dec 13
2023
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
45,000
+20.08%
|
$45,000
$1.0 P/Share
|
|
Dec 19
2022
|
Nola E Masterson |
BUY
Open market or private purchase
|
Direct |
300
+5.46%
|
$600
$2.64 P/Share
|
|
Dec 19
2022
|
John Bernard Payne President and CEO |
BUY
Open market or private purchase
|
Direct |
57
+0.6%
|
$114
$2.5 P/Share
|
|
Dec 13
2022
|
Alison A Cornell |
BUY
Open market or private purchase
|
Direct |
12,000
+30.77%
|
$36,000
$3.0 P/Share
|
|
Sep 14
2022
|
Christopher D. Maggiore |
BUY
Open market or private purchase
|
Direct |
7,200
+0.44%
|
$21,600
$3.54 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 445K shares |
|---|---|
| Open market or private purchase | 258K shares |